Una Health

Born out of a shared vision during the challenging times of the first coronavirus wave in 2021, Una Health embarked on a mission to revolutionize metabolic care. The founders, Pascal Grimm, Dominic Steele, and Dr. Matthew Fenech, connected virtually, driven by a common goal to address the escalating global challenge of metabolic dysfunctions like type 2 diabetes. What began as a shared interest rapidly materialized into a dynamic health technology company poised to make a significant impact. The trio's diverse expertise—Grimm's background in healthcare consulting, Steele's experience in neuroscience and healthtech product development for diabetes, and Fenech's insights as a research doctor emphasizing holistic care—formed a complementary foundation for Una Health's innovative approach.

Una Health's journey is one of leveraging cutting-edge technology to empower individuals. The company develops personalized digital therapies, ingeniously combining biosensor technology, artificial intelligence, and behavioral science. Their core focus is to help people understand their unique metabolic responses and make sustainable lifestyle changes. This data-driven methodology allows for tailored recommendations, moving beyond generic advice to provide truly personal insights into nutrition and activity. A significant milestone was achieved when Una Health's nutrition-focused application for type 2 diabetes received DiGA certification in Germany, allowing for full reimbursement by the German statutory health insurance system. This marked a crucial step in making their innovative solution accessible to a wider population. With a remote-first team fostering diversity and inclusivity, Una Health is not just building a product; they are cultivating a new paradigm in managing chronic conditions, aiming to expand their reach from Germany to Europe and eventually, globally, to help millions reclaim their health and vitality.